The World Bispecific Summit provides a technically focused view of the advances driving bispecifics, multispecifics, and cell engagers toward clinical validation. Real-world case studies help attendees refine molecular design, improve specificity and therapeutic windows, address developability and CMC risks, and evaluate emerging approaches such as masking and conditional activation. Coverage spans the full development pathway—from target biology and antibody engineering through translational science and early clinical development—making the insights directly relevant to pipeline decisions. Its specialized community also creates valuable opportunities to engage with senior scientists and decision-makers evaluating new technologies, platforms, and development partners.

Date: September 15-17, 2026
Location: The Westin Boston Seaport District Boston, Massachusetts

https://bispecific.com/

JOIN US!

Meet with Catalent’s biologics experts to discuss strategies for overcoming the development and manufacturing challenges associated with complex molecules, including bispecific and multispecific antibodies. Learn how our integrated analytical, cell line development, process development, and manufacturing capabilities can help accelerate timelines from gene to drug substance while reducing development risk.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Speaker: Rachel Kravitz , Principal Scientist, R&D, Catalent
Date/Time: 11:30 AM-12:00 PM ET, September 17, 2026
Title: From Design to Delivery: Enabling Bispecific Antibodies at mAb-Like Timelines with GPEx® Lightning and an Integrated PD Toolbox

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™